Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125037314 | 12503731 | 4 | F | 20160604 | 20160726 | 20160628 | 20160803 | EXP | US-ELI_LILLY_AND_COMPANY-US201606007430 | ELI LILLY AND CO | 67.00 | YR | F | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125037314 | 12503731 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | UNK, UNKNOWN | U | U | 21368 | TABLET | |||||||
| 125037314 | 12503731 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Subcutaneous | 11.25NKM, CONTINUOUS, 0.01025 MCG/KG | U | 0 | |||||||||
| 125037314 | 12503731 | 3 | SS | SILDENAFIL. | SILDENAFIL | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 4 | SS | SELEXIPAG | SELEXIPAG | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | BID | |||||||
| 125037314 | 12503731 | 5 | SS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 1412805A | 0 | 5 | MG | TABLET | QD | |||||
| 125037314 | 12503731 | 6 | C | TORSEMIDE. | TORSEMIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 7 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 8 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 9 | C | PROTONIX /00661201/ | OMEPRAZOLE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 10 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 11 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 12 | C | DIGOXIN. | DIGOXIN | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 13 | C | FENOFIBRATE. | FENOFIBRATE | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 14 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125037314 | 12503731 | 15 | C | TRAVATAN Z | TRAVOPROST | 1 | 0 | ||||||||||||
| 125037314 | 12503731 | 16 | C | DEPO-MEDROL | METHYLPREDNISOLONE ACETATE | 1 | U | 0 | |||||||||||
| 125037314 | 12503731 | 17 | C | KLOR-CON | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 125037314 | 12503731 | 18 | C | RESTASIS | CYCLOSPORINE | 1 | U | 0 | |||||||||||
| 125037314 | 12503731 | 19 | C | DIAZEPAM. | DIAZEPAM | 1 | U | 0 | |||||||||||
| 125037314 | 12503731 | 20 | C | PERCOCET /00446701/ | ACETAMINOPHENOXYCODONE HYDROCHLORIDEOXYCODONE TEREPHTHALATE | 1 | U | 0 | |||||||||||
| 125037314 | 12503731 | 21 | C | METOPROLOL SUCCINATE. | METOPROLOL SUCCINATE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125037314 | 12503731 | 1 | Product used for unknown indication |
| 125037314 | 12503731 | 2 | Pulmonary arterial hypertension |
| 125037314 | 12503731 | 3 | Product used for unknown indication |
| 125037314 | 12503731 | 4 | Pulmonary hypertension |
| 125037314 | 12503731 | 5 | Pulmonary arterial hypertension |
| 125037314 | 12503731 | 6 | Product used for unknown indication |
| 125037314 | 12503731 | 7 | Product used for unknown indication |
| 125037314 | 12503731 | 8 | Product used for unknown indication |
| 125037314 | 12503731 | 9 | Product used for unknown indication |
| 125037314 | 12503731 | 10 | Product used for unknown indication |
| 125037314 | 12503731 | 11 | Product used for unknown indication |
| 125037314 | 12503731 | 12 | Product used for unknown indication |
| 125037314 | 12503731 | 13 | Product used for unknown indication |
| 125037314 | 12503731 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125037314 | 12503731 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125037314 | 12503731 | Dizziness | |
| 125037314 | 12503731 | Fall | |
| 125037314 | 12503731 | Headache | |
| 125037314 | 12503731 | Myalgia | |
| 125037314 | 12503731 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125037314 | 12503731 | 2 | 20160415 | 20160616 | 0 | |
| 125037314 | 12503731 | 4 | 20160613 | 0 | ||
| 125037314 | 12503731 | 5 | 20160607 | 0 |